Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy

Impact · against what's priced in

Qualigen Therapeutics is undergoing a total business pivot from biotech to AI/Web3, coupled with a change in control to Faraday Future. While the rebrand is cosmetic, the structural shift in ownership and the upcoming strategic roadmap create a speculative catalyst for both companies.

QLGN+0.60

No priced-in read yet